( + )-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated σ1 sites

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 21-28

  Kamei, Hiroyuki ^a   Kameyama, Tsutomu ^a   Nabeshima, Toshitaka ^a,b  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Conditioned fear stress; Motor suppression; Phencyclidine receptor; Phenytoin; Receptor

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; ANTICONVULSIVE AGENT; DEXTROMETHORPHAN; DIZOCILPINE; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PENTAZOCINE; PHENCYCLIDINE; PHENCYCLIDINE RECEPTOR; PHENYTOIN; SIGMA 1 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR ANTAGONIST; SIGMA OPIATE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; FEAR; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; DEXTROMETHORPHAN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; MOTOR ACTIVITY; PHENAZOCINE; PHENCYCLIDINE; PHENYTOIN; PYRIMIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SIGMA; STRESS;

EID: 0029867876     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00830-6     Document Type: Article

References (31)

1. 3H]-( + )-pentazocine, a highly potent and selective radioligand for cr receptors, FEBS Lett. 251, 53.
2. 3H]-( + )pentazocine-defmed σ recognition sites by phenytoin, Life Sci. 53, 41.
3. Fanselow, M.S., 1980, Conditional and unconditional components of post-shock freezing, Pavlov J. Biol. Sci. 15, 177.
4. Gundlach A.L., B.L. Largent, S.H. Snyder, 1985, Phencyclidine and σ opiate receptors in brain: biochemical and autoradiographical differentiation, Eur. J. Pharmacol. 113, 465.
5. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine, J. Neurosci. 6, 1757.
6. Hellewell, S.B. and W.D. Bowen, 1990, A sigma-like binding site in rat pheochromocytoma (PC 12) cells: Decreased affinity for ( + )-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain, Brain Res. 527, 244.
7. Holtzman, S.G., 1994, Discriminative stimulus effects of dextromethorphan in the rat, Psychopharmacology 116, 249.
8. Itzhak, Y., I. Stein, S.-H. Zhang, C.O. Kassim and D. Cristante, 1991, Binding of sigma ligands to C57BL/6 mouse brain membranes: effect of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma receptor subtypes, J. Pharmacol. Exp. Ther. 257, 141.
9. Kamei, H., T. Kameyama and T. Nabeshima, 1994, SKF-10,047 reverses stress-induced motor suppression: interaction with dopaminergic system, Eur. J. Pharmacol. 260, 39.
10. Kameyama, T. and M. Nagasaka, 1982a, Effects of apomorphine and diazepam in a quickly learned conditioned suppression in rats, Pharmacol. Biochem. Behav. 17, 59.
11. Kameyama, T. and M. Nagasaka, 1982b, The effect of analgesics on quickly learned conditioned suppression in mice, Neuropharmacology 21, 1283.
12. 3H)( + )-3-PPP label pharmacologically distinct σ binding sites in guinea pig brain membranes, Eur. J. Pharmacol. 193, 21.
13. Largent, B.L., H. Wikstrom, A.M. Snowman and S.H. Snyder, 1988, Novel antipsychotic drugs share high affinity for σ receptors, Eur. J. Pharmacol. 155, 345.
14. Martin, W.R., G.G. Eades, J.A. Thompson, R.A. Huppler and P.E. Gilbert, 1976, The effect of morphine and nalorphine-like drugs in non-dependent and morphine dependent chronic spinal dog, J. Pharmacol. Exp. Ther. 197, 517.
15. McCann D.J. and T.P. Su, 1992, Stimulation of σ ligand binding by phenytoin: apparent binding site and ligand specificity, in: Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?, eds. J.-M. Kamenka and E.F. Domino (NPP Books, Ann Arbor) p. 295.
16. Misra, A., 1978, Factors affecting the action of narcotics, in: Metabolism of Opiates, eds. M.L. Adler, L. Manara and R. Samanin (Raven Press, New York) p. 297.
17. Murray, T.F. and M.E. Leid, 1984, Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes, Life Sci. 34, 1899.
18. 3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine, Mol. Pharmacol. 35, 1.
19. Nabeshima, T., K. Yamada and T. Kameyama, 1983, Effect of opiate agonists on the conditioned suppression in motility of mice, Neurosci. Lett. 39, 301.
20. Nabeshima, T., H. Kamei and T. Kameyama, 1988, A role played by sigma receptors in the conditioned suppression of motility in mice, Psycopharmacology 94, 515.
21. Okuyama, S., Y. Imagawa, S. Ogawa, H. Araki, A. Ajima, M. Tanaka, M. Muramatsu, A. Nakazato, K. Yamaguchi, M. Yoshida and S. Otomo, 1993, NE-100, a novel σ receptor ligand - in vivo tests, Life Sci. 53, 18.
22. Quirion R., P.C. Chicheportiche, K.M. Contreras, D. Johnson, S. Lodge, W. Tam, J.H. Woods and S.R. Zukin, 1987, Classification and nomenclature of phencyclidine and sigma receptor sites, Trends Pharmacol. Sci. 10, 444.
23. Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.P. Su, S.W. Tam and D.P. Tayllor, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci. 13, 85.
24. Rogawski, M.A. and R.J. Porter, 1990, Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds, Pharmacol. Rev. 42, 223.
25. 3H]tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by σ ligands, Mol. Pharmacol. 39, 222.
26. Tam, S.W., 1983, Naloxone-inaccessible σ receptor in rat central nervous system, Proc. Natl. Acad. Sci. USA 80, 6703.
27. Walker, J.M., W.D. Bowen, F.O. Walker, R.R. Matsumoto, B.D. Costa and K.C. Rice, 1990, Sigma receptors: biology and function, Pharmacol. Rev. 42, 355.
28. 3H]tolyl)guanidine: a selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs, Proc. Natl. Acad. Sci. USA 83, 8784.
29. 3H]haloperidol to sigma receptors in the mouse brain, J. Chem. Neuroanat. 3, 347.
30. Wong, E.H.F., J.A. Kemp, T. Priestly, A.R. Knight, G.N. Woodruff and L.L. Iversen, 1986, The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist, Proc. Natl. Acad. Sci. USA 83, 7104.
31. Yamada, K and T. Nabeshima, 1995, Stress-induced behavioral responses and multiple opioid systems in the brain, Behav. Brain Res. 67, 133.